The results showed that IL-1β, IL-6, and TNF-α levels were observably increased in the M group, and QJ treatment significantly downregulated this change, which further confirmed that QJ inhibited CCl4-induced liver inflammation (Figure 1D). This evidence concerns the gene IL6 and Hepatitis.